Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12352200
NACRES:
NA.54
Storage temp.:
2-8°C
form
powder
packaging
pkg of 27 g
manufacturer/tradename
Roche
storage temp.
2-8°C
General description
Blocking reagent is used for blocking of nonspecific binding sites in ELISA procedures.
Application
For research use only. Not for use in diagnostic procedures.
Blocking reagent has been used as a blocking reagent in:
Blocking reagent has been used as a blocking reagent in:
- ELISA
- Immunofluorescence
- In situ hybridization
Preparation Note
Storage conditions (working solution): Autoclaved stock solution can be stored for several days to one week either unopened at 15 to 25 °C or at 2 to 8 °C after opening. Alternatively, the stock solution can be stored in aliquots at -15 to -15 °C for up to 6 months.
Other Notes
For life science research only. Not for use in diagnostic procedures.
Still not finding the right product?
Explore all of our products under Blocking Reagent
Storage Class
11 - Combustible Solids
wgk
WGK 1
flash_point_f
does not flash
flash_point_c
does not flash
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Sara Mravinacova et al.
New biotechnology, 66, 46-52 (2021-10-11)
Highly accurate serological tests are key to assessing the prevalence of SARS-CoV-2 antibodies and the level of immunity in the population. This is important to predict the current and future status of the pandemic. With the recent emergence of new
David Drews et al.
BMC developmental biology, 9, 45-45 (2009-07-30)
The transcription factor Yin Yang 2 (YY2) shares a structural and functional highly homologue DNA-binding domain with the ubiquitously expressed YY1 protein, which has been implicated in regulating fundamental biological processes. However, the biological relevance of YY2 has not been
Anja K Wege et al.
mAbs, 6(4), 968-977 (2014-05-30)
Humanized tumor mice (HTM) were generated by the co-transplantation of human hematopoietic stem cells and human breast cancer cells overexpressing HER2 into neonatal NOD-scid IL2Rγ(null) (NSG) mice. These mice are characterized by the development of a human immune system in